Position statements

Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing interest using the best available evidence.

  • Lung cancer screening using low-dose computed tomography

    Revised & updated: 2015
    First published: 2015
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    The Australian Government Department of Health's Standing Committee on Screening has considered lung cancer screening and prepared a position statement on lung cancer screening using low-dose computed tomography, released in 2015.

    On the basis of the current evidence and in line with the Population Based Screening Framework, the Standing Committee on Screening does not support an Australian lung cancer screening program, either for the general population or for high risk populations. The Standing Committee on Screening will continue to evaluate and advise on emerging evidence on lung cancer screening. The position statement provides a brief overview of the main points arising from the lung cancer epidemiology literature and explores some key issues related to lung cancer screening in the context of the Australian screening principles. read more

  • Early detection of breast cancer

    Revised & updated: 2015, 2009
    First published: 2004
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    This position statement applies to the early detection of breast cancer in asymptomatic women (women without breast changes). The statement does not apply to diagnostic tests used to assess individual women presenting with breast changes. read more

  • Overdiagnosis from mammographic screening

    Revised & updated: 2014, 2010
    First published: 2008
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    This position statement outlines the evidence for mammographic screening and estimates of overdiagnosis. “Overdiagnosis” from breast screening does not refer to error or misdiagnosis, but rather refers to breast cancer diagnosed by screening that would not otherwise have been diagnosed during a woman’s lifetime. “Overdiagnosis” includes all instances where cancers detected through screening (ductal carcinoma in situ or invasive breast cancer) might never have progressed to become symptomatic during a woman’s life, i.e., cancer that would not have been detected in the absence of screening.1 It is not possible to precisely predict at diagnosis, to which cancers overdiagnosis would apply. read more

  • Hormone Replacement Therapy (HRT) and risk of breast cancer

    Revised & updated: 2010
    First published: 2008
    Resource status: Greater than 5 years

    This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

    Summary:

    This position statement applies only to Hormone Replacement Therapy (HRT) and breast cancer risk in women – it does not address other risks or benefits to women from HRT usage. read more

  • Complementary and alternative therapies

    Revised & updated: 2010
    First published: 2004
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    Although there is some looseness in usage of the terms, complementary therapies refer to those therapies that do not replace or preclude conventional medical therapies, whereas alternative therapies are treatment options outside the orthodox range, that may be used in place of conventional treatments. read more

  • Statement on use of thermography to detect breast cancer

    Revised & updated: 2010
    First published: 1999
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    Cancer Australia does not recommend the use of thermography for the early detection of breast cancer. read more

  • Lifestyle risk factors and the primary prevention of cancer

    Published: 2015
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    It is estimated that at least one third of all cancer cases are preventable, and that potentially more than half of all cancers could be avoided through a combination of healthy lifestyle and regular screening. Prevention offers the most cost-effective long-term strategy for the control of cancer across the population.  This positon statement includes recommendations for adults to reduce their risk of cancer and stay healthy. read more

  • Cancer clusters

    Published: 2012
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    National Health and Medical Research Council (NHMRC) has released a position statement to provide information about the assessment and management of cancer clusters. The statement is intended to support guidelines issued by State and Territory Health Departments and Cancer Councils. read more

  • Surveillance of women at high or potentially high risk of ovarian cancer

    Published: 2009
    Resource status: Greater than 5 years

    This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

    Summary:

    Familial clusters of ovarian cancer have been recognised for many years and family history has been identified as a risk factor in epidemiological studies that have investigated its role. read more

  • Population screening and early detection of ovarian cancer in asymptomatic women

    Published: 2009
    Resource status: Greater than 5 years

    This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

    Summary:

    This position statement and supporting background information has been endorsed by the following colleges and agencies: the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, the Royal Australian College of General Practitioners, the Australian Society Gynaecologic Oncologists, Cancer Council Australia, the Screening Subcommittee of the Department of Health and Ageing, and The Royal College of Pathologists of Australasia. read more